Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis

It is currently believed that innate immunity is unable to prevent the spread of SARS-CoV-2 from the upper airways to the alveoli of high-risk groups of patients. SARS-CoV-2 replication in ACE-2-expressing pneumocytes can drive the diffuse alveolar injury through the cytokine storm and immunothrombo...

Descripción completa

Detalles Bibliográficos
Autores principales: Motta Junior, Jarbas da Silva, Miggiolaro, Anna Flavia Ribeiro dos Santos, Nagashima, Seigo, de Paula, Caroline Busatta Vaz, Baena, Cristina Pellegrino, Scharfstein, Julio, de Noronha, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530169/
https://www.ncbi.nlm.nih.gov/pubmed/33042157
http://dx.doi.org/10.3389/fimmu.2020.574862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530169/
https://www.ncbi.nlm.nih.gov/pubmed/33042157
http://dx.doi.org/10.3389/fimmu.2020.574862

Ejemplares similares